Biogen Idec Inc (BIIB) 401.71 $BIIB
Fidelity Contrafund: Beating the Market the Old-Fashioned Way
John Rosevear, The Motley Fool - Motley Fool - Sat Apr 25, 2:05PM CDT
Fidelity Contrafund has long been one of the legends of Wall Street. Back in the 1990s, it was one of the funds that helped build Fidelity Investments' reputation as a stock-picking powerhouse. But does today's Contrafund live up to the legends? ...
BIIB: 401.71 (-28.57), FB: 81.53 (-0.88), UNH: 118.69 (+0.43), DIS: 109.53 (+0.53), WFC: 54.70 (-0.16), GOOG: 565.06 (+18.06), GOOGL: 573.66 (+16.20), AAPL: 130.28 (+0.61), CL: 69.17 (-0.05)
With Market Back In Uptrend, IBD 50 Growth Names Thrive
at Investor's Business Daily - Fri Apr 24, 5:29PM CDT
The bears are watching in disbelief as the Nasdaq and S&P 500 hit new closing highs. How can the market go higher with so many questions about the first-quarter earnings season, the health of the economy and the prospects for rising interest rates,...
MNST: 141.78 (+1.42), BIIB: 401.71 (-28.57), HAR: 145.10 (-1.39), CRTO: 43.52 (+0.30), FLT: 162.24 (-0.42), ULTA: 157.08 (+0.09), ALK: 68.30 (+1.96), ATHM: 53.31 (+0.92), PAYC: 32.91 (-0.14)
Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 5:28PM CDT
Merck reported encouraging data from an ongoing pivotal phase III program evaluating its grazoprevir/elbasvir.
BIIB: 401.71 (-28.57), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82)
Intercept Pharmaceuticals Releases Data on Lead Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 4:24PM CDT
Intercept Pharmaceuticals (ICPT) released post-hoc analyses from the phase IIb trial, FLINT, on lead candidate obeticholic acid (OCA) in patients suffering from NASH.
BIIB: 401.71 (-28.57), HZNP: 31.75 (+0.97), ICPT: 283.20 (-2.22)
Biogen Inc Earnings: Tecfidera Turbulance
Brian Orelli, The Motley Fool - Motley Fool - Fri Apr 24, 4:17PM CDT
Biotech darling Biogen had a rough day, ending down 6.6%, despite putting up some impressive year-over-year comparisons: revenue increased 20% year over year in the first quarter, and adjusted earnings per share were up 55%. Of course, the...
BIIB: 401.71 (-28.57)
Stocks Finish Solid Week; Akorn Restates 2014 Revenue
at Investor's Business Daily - Fri Apr 24, 3:55PM CDT
Stocks settled back slightly going into the close Friday, but managed to hold most of the day's gains despite weakness in chip stocks. But after the close, leading drugmaker Akorn (AKRX) dropped sharply. It announced it had preliminarily discovered...
SBUX: 51.84 (+2.41), BIIB: 401.71 (-28.57), CAVM: 65.63 (-4.51), AMZN: 445.10 (+55.11), MTSI: 31.41 (-1.92), AKRX: 55.24 (-0.68), TXN: 54.73 (+0.01), SKX: 89.66 (+2.79), DPZ: 113.96 (+4.73), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), AVGO: 119.50 (-4.57)
Biogen (BIIB) George A. Scangos, Ph.D. on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Apr 24, 3:15PM CDT
BIIB: 401.71 (-28.57)
S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump
at The Street - Fri Apr 24, 3:08PM CDT
The S&P 500 and the Nasdaq close the week at all-time highs thanks to an earnings-driven rally.
BIIB: 401.71 (-28.57), F: 15.77 (+0.01), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), JBLU: 19.89 (+0.14), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), TWTR: 50.82 (-0.59), AAPL: 130.28 (+0.61), GPRO: 44.73 (-1.35), AMZN: 445.10 (+55.11), VFC: 73.70 (-0.21), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), DWA: 26.00 (+0.25), EXPE: 98.89 (-0.03), YELP: 50.61 (+0.29), CMCSA: 59.64 (+0.41)
Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)
S&P 500 Hits Intraday Record as Time Warner Cable Spikes
at The Street - Fri Apr 24, 2:30PM CDT
Stocks are higher late Friday, boosted by a rally in shares of Amazon, Google and Microsoft.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), COP: 67.51 (-0.75), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), RDS.A: 62.76 (-0.20), TOT: 51.87 (-0.45), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41), XLE: 81.98 (-0.47)
Chips Fall, But Nasdaq Holds Up; Avago Slices 50-Day Line
at Investor's Business Daily - Fri Apr 24, 2:00PM CDT
Stocks held onto gains going into the last hour of trading Friday, but chip stocks sank. The Nasdaq rose 0.8%; the S&P 500 gained 0.3% and the Dow Jones industrial average picked up 0.2%. Volume was running lower on the NYSE and higher on the Nasdaq...
SBUX: 51.84 (+2.41), AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), CAVM: 65.63 (-4.51), MTSI: 31.41 (-1.92), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), AVGO: 119.50 (-4.57)
Biogen Q1 Misses Estimates As Tecfidera Stalls
at Investor's Business Daily - Fri Apr 24, 1:35PM CDT
Big-cap biotech Biogen (BIIB) missed Wall Street's Q1 estimates Friday as its multiple-sclerosis drug Tecfidera ran into unexpected headwinds, sending its stock down to a two-month low. Biogen's earnings excluding one-time items rose 55% over the...
BIIB: 401.71 (-28.57), NVS: 104.28 (-1.22)
French biotech's B-vitamin beats placebo in Phase 3 MS study
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 11:57AM CDT
BIIB: 401.71 (-28.57), OPXA: 0.43 (-0.01), FWP: 32.03 (-0.06), RCPT: 169.88 (-1.26), ABBV: 66.07 (+1.82), TEVA: 64.41 (+1.16), SNY: 51.75 (-0.01), CHRS: 23.52 (-0.88), NVS: 104.28 (-1.22)
Stocks Firm Up As Amazon, Starbucks Gap To New Highs
at Investor's Business Daily - Fri Apr 24, 11:09AM CDT
Four big-cap Nasdaq stocks did the bulk of the heavy lifting as stocks firmed up going into the noon hour Friday. The Nasdaq rose 0.8%; the S&P 500 gained 0.3% and the Dow Jones industrial average pulled into positive territory, up 0.2%. Volume was...
SBUX: 51.84 (+2.41), BIIB: 401.71 (-28.57), AMZN: 445.10 (+55.11), GOOGL: 573.66 (+16.20), ALK: 68.30 (+1.96), MSFT: 47.87 (+4.53)
Jim Cramer Loves Regeneron, Sees Shares Headed to $500
at The Street - Fri Apr 24, 10:47AM CDT
TheStreet's Jim Cramer remains bullish on several biotech stocks.
BIIB: 401.71 (-28.57), QQQ: 110.54 (+1.48), XBI: 233.86 (-2.86), IBB: 363.70 (-3.98), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), INTC: 32.08 (-0.27), GOOG: 565.06 (+18.06), AAPL: 130.28 (+0.61), REGN: 480.09 (+0.01), CELG: 118.71 (+2.62)
Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory
at The Street - Fri Apr 24, 9:55AM CDT
The Nasdaq and S&P 500 hover at record highs.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), SBUX: 51.84 (+2.41), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41)
Biogen Misses on 1Q Earnings, Tecfidera Falls Short - Analyst Blog
Arpita Dutt - Zacks Investment Research - Fri Apr 24, 9:52AM CDT
Biogen's (BIIB) first quarter results disappointed leading to concerns regarding the growth prospects of Tecfidera.
BIIB: 401.71 (-28.57), CYTX: 0.99 (+0.01), AVEO: 1.92 (-0.08), OSIR: 16.33 (-0.26)
Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives
at Investor's Business Daily - Fri Apr 24, 9:35AM CDT
Tech stocks took early control Friday, as the market posted a mixed launch in solid trade. The Nasdaq jumped 0.5%, climbing well into new territory above its 15-year high. The Dow Jones industrial average slipped 0.1%. The S&P 500 added 0.1%, leaving...
BIIB: 401.71 (-28.57), NOAH: 33.79 (+0.63), MMM: 158.99 (-0.67), AMZN: 445.10 (+55.11), NKE: 100.95 (-0.16), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), BA: 148.40 (-1.47), MSFT: 47.87 (+4.53)
4 Nasdaq Stocks at All-Time Highs - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Apr 24, 9:27AM CDT
The Nasdaq touched an all-time on Thursday, breaching a record level achieved during the dot-com boom.
NVEE: 19.99 (+1.34), TSCO: 90.98 (-0.28), MNST: 141.78 (+1.42), BIIB: 401.71 (-28.57), DLTR: 81.14 (+0.13), GILD: 103.69 (-1.52), FB: 81.53 (-0.88), AMGN: 167.91 (-1.26), GOOGL: 573.66 (+16.20), ULTA: 157.08 (+0.09), MSFT: 47.87 (+4.53), INTU: 101.22 (-0.22), AAPL: 130.28 (+0.61)
Shares of BIIB Up 22.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 24, 9:25AM CDT
SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on December 2nd, 2014 at $330.03. In approximately 5 months, Biogen Idec has returned 22.63% as of today's recent price of $404.70.
BIIB: 401.71 (-28.57)
Fidelity Contrafund: Beating the Market the Old-Fashioned Way
John Rosevear, The Motley Fool - Motley Fool - Sat Apr 25, 2:05PM CDT
Fidelity Contrafund has long been one of the legends of Wall Street. Back in the 1990s, it was one of the funds that helped build Fidelity Investments' reputation as a stock-picking powerhouse. But does today's Contrafund live up to the legends? ...
BIIB: 401.71 (-28.57), FB: 81.53 (-0.88), UNH: 118.69 (+0.43), DIS: 109.53 (+0.53), WFC: 54.70 (-0.16), GOOG: 565.06 (+18.06), GOOGL: 573.66 (+16.20), AAPL: 130.28 (+0.61), CL: 69.17 (-0.05)
With Market Back In Uptrend, IBD 50 Growth Names Thrive
at Investor's Business Daily - Fri Apr 24, 5:29PM CDT
The bears are watching in disbelief as the Nasdaq and S&P 500 hit new closing highs. How can the market go higher with so many questions about the first-quarter earnings season, the health of the economy and the prospects for rising interest rates,...
MNST: 141.78 (+1.42), BIIB: 401.71 (-28.57), HAR: 145.10 (-1.39), CRTO: 43.52 (+0.30), FLT: 162.24 (-0.42), ULTA: 157.08 (+0.09), ALK: 68.30 (+1.96), ATHM: 53.31 (+0.92), PAYC: 32.91 (-0.14)
Merck Reports Encouraging Data on HCV Combo Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 5:28PM CDT
Merck reported encouraging data from an ongoing pivotal phase III program evaluating its grazoprevir/elbasvir.
BIIB: 401.71 (-28.57), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82)
Intercept Pharmaceuticals Releases Data on Lead Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 4:24PM CDT
Intercept Pharmaceuticals (ICPT) released post-hoc analyses from the phase IIb trial, FLINT, on lead candidate obeticholic acid (OCA) in patients suffering from NASH.
BIIB: 401.71 (-28.57), HZNP: 31.75 (+0.97), ICPT: 283.20 (-2.22)
Biogen Inc Earnings: Tecfidera Turbulance
Brian Orelli, The Motley Fool - Motley Fool - Fri Apr 24, 4:17PM CDT
Biotech darling Biogen had a rough day, ending down 6.6%, despite putting up some impressive year-over-year comparisons: revenue increased 20% year over year in the first quarter, and adjusted earnings per share were up 55%. Of course, the...
BIIB: 401.71 (-28.57)
Stocks Finish Solid Week; Akorn Restates 2014 Revenue
at Investor's Business Daily - Fri Apr 24, 3:55PM CDT
Stocks settled back slightly going into the close Friday, but managed to hold most of the day's gains despite weakness in chip stocks. But after the close, leading drugmaker Akorn (AKRX) dropped sharply. It announced it had preliminarily discovered...
SBUX: 51.84 (+2.41), BIIB: 401.71 (-28.57), CAVM: 65.63 (-4.51), AMZN: 445.10 (+55.11), MTSI: 31.41 (-1.92), AKRX: 55.24 (-0.68), TXN: 54.73 (+0.01), SKX: 89.66 (+2.79), DPZ: 113.96 (+4.73), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), AVGO: 119.50 (-4.57)
Biogen (BIIB) George A. Scangos, Ph.D. on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Apr 24, 3:15PM CDT
BIIB: 401.71 (-28.57)
S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump
at The Street - Fri Apr 24, 3:08PM CDT
The S&P 500 and the Nasdaq close the week at all-time highs thanks to an earnings-driven rally.
BIIB: 401.71 (-28.57), F: 15.77 (+0.01), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), JBLU: 19.89 (+0.14), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), TWTR: 50.82 (-0.59), AAPL: 130.28 (+0.61), GPRO: 44.73 (-1.35), AMZN: 445.10 (+55.11), VFC: 73.70 (-0.21), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), DWA: 26.00 (+0.25), EXPE: 98.89 (-0.03), YELP: 50.61 (+0.29), CMCSA: 59.64 (+0.41)
Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)
S&P 500 Hits Intraday Record as Time Warner Cable Spikes
at The Street - Fri Apr 24, 2:30PM CDT
Stocks are higher late Friday, boosted by a rally in shares of Amazon, Google and Microsoft.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), COP: 67.51 (-0.75), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), RDS.A: 62.76 (-0.20), TOT: 51.87 (-0.45), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41), XLE: 81.98 (-0.47)
Chips Fall, But Nasdaq Holds Up; Avago Slices 50-Day Line
at Investor's Business Daily - Fri Apr 24, 2:00PM CDT
Stocks held onto gains going into the last hour of trading Friday, but chip stocks sank. The Nasdaq rose 0.8%; the S&P 500 gained 0.3% and the Dow Jones industrial average picked up 0.2%. Volume was running lower on the NYSE and higher on the Nasdaq...
SBUX: 51.84 (+2.41), AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), CAVM: 65.63 (-4.51), MTSI: 31.41 (-1.92), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), AVGO: 119.50 (-4.57)
Biogen Q1 Misses Estimates As Tecfidera Stalls
at Investor's Business Daily - Fri Apr 24, 1:35PM CDT
Big-cap biotech Biogen (BIIB) missed Wall Street's Q1 estimates Friday as its multiple-sclerosis drug Tecfidera ran into unexpected headwinds, sending its stock down to a two-month low. Biogen's earnings excluding one-time items rose 55% over the...
BIIB: 401.71 (-28.57), NVS: 104.28 (-1.22)
French biotech's B-vitamin beats placebo in Phase 3 MS study
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 11:57AM CDT
BIIB: 401.71 (-28.57), OPXA: 0.43 (-0.01), FWP: 32.03 (-0.06), RCPT: 169.88 (-1.26), ABBV: 66.07 (+1.82), TEVA: 64.41 (+1.16), SNY: 51.75 (-0.01), CHRS: 23.52 (-0.88), NVS: 104.28 (-1.22)
Stocks Firm Up As Amazon, Starbucks Gap To New Highs
at Investor's Business Daily - Fri Apr 24, 11:09AM CDT
Four big-cap Nasdaq stocks did the bulk of the heavy lifting as stocks firmed up going into the noon hour Friday. The Nasdaq rose 0.8%; the S&P 500 gained 0.3% and the Dow Jones industrial average pulled into positive territory, up 0.2%. Volume was...
SBUX: 51.84 (+2.41), BIIB: 401.71 (-28.57), AMZN: 445.10 (+55.11), GOOGL: 573.66 (+16.20), ALK: 68.30 (+1.96), MSFT: 47.87 (+4.53)
Jim Cramer Loves Regeneron, Sees Shares Headed to $500
at The Street - Fri Apr 24, 10:47AM CDT
TheStreet's Jim Cramer remains bullish on several biotech stocks.
BIIB: 401.71 (-28.57), QQQ: 110.54 (+1.48), XBI: 233.86 (-2.86), IBB: 363.70 (-3.98), GOOGL: 573.66 (+16.20), MSFT: 47.87 (+4.53), INTC: 32.08 (-0.27), GOOG: 565.06 (+18.06), AAPL: 130.28 (+0.61), REGN: 480.09 (+0.01), CELG: 118.71 (+2.62)
Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory
at The Street - Fri Apr 24, 9:55AM CDT
The Nasdaq and S&P 500 hover at record highs.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), SBUX: 51.84 (+2.41), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41)
Biogen Misses on 1Q Earnings, Tecfidera Falls Short - Analyst Blog
Arpita Dutt - Zacks Investment Research - Fri Apr 24, 9:52AM CDT
Biogen's (BIIB) first quarter results disappointed leading to concerns regarding the growth prospects of Tecfidera.
BIIB: 401.71 (-28.57), CYTX: 0.99 (+0.01), AVEO: 1.92 (-0.08), OSIR: 16.33 (-0.26)
Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives
at Investor's Business Daily - Fri Apr 24, 9:35AM CDT
Tech stocks took early control Friday, as the market posted a mixed launch in solid trade. The Nasdaq jumped 0.5%, climbing well into new territory above its 15-year high. The Dow Jones industrial average slipped 0.1%. The S&P 500 added 0.1%, leaving...
BIIB: 401.71 (-28.57), NOAH: 33.79 (+0.63), MMM: 158.99 (-0.67), AMZN: 445.10 (+55.11), NKE: 100.95 (-0.16), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), BA: 148.40 (-1.47), MSFT: 47.87 (+4.53)
4 Nasdaq Stocks at All-Time Highs - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Apr 24, 9:27AM CDT
The Nasdaq touched an all-time on Thursday, breaching a record level achieved during the dot-com boom.
NVEE: 19.99 (+1.34), TSCO: 90.98 (-0.28), MNST: 141.78 (+1.42), BIIB: 401.71 (-28.57), DLTR: 81.14 (+0.13), GILD: 103.69 (-1.52), FB: 81.53 (-0.88), AMGN: 167.91 (-1.26), GOOGL: 573.66 (+16.20), ULTA: 157.08 (+0.09), MSFT: 47.87 (+4.53), INTU: 101.22 (-0.22), AAPL: 130.28 (+0.61)
Shares of BIIB Up 22.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 24, 9:25AM CDT
SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on December 2nd, 2014 at $330.03. In approximately 5 months, Biogen Idec has returned 22.63% as of today's recent price of $404.70.
BIIB: 401.71 (-28.57)
